Synapse - A double-blind placebo-controlled randomized phase II clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from anti-EGFR therapies

A double-blind placebo-controlled randomized phase II clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from anti-EGFR therapies Meeting Abstract

Authors:	Purim, O.; Patel, A.; Wainberg, Z. A.; Dotan, E.; Shelach, N.; Tahover, E.; Corn, B.; Ribas, A.; Lacouture, M.
Abstract Title:	A double-blind placebo-controlled randomized phase II clinical trial to assess the efficacy of a topical BRAF inhibitor for acneiform rash toxicities from anti-EGFR therapies
Meeting Title:	Ann. Oncol.
Journal Title:	Annals of Oncology
Volume:	36
ISSN:	0923-7534
Publisher:	Oxford University Press
Date Published:	2025-07-01
Start Page:	S4
End Page:	S5
Language:	English
ACCESSION:	WOS:001545246300007
DOI:	10.1016/j.annonc.2025.05.017
PROVIDER:	wos
Notes:	Meeting Abstract -- 1 -- Source: Wos